Belvedere Trading LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Belvedere Trading LLC

  • $77.2 Billion
  • Q1 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 25, 2022
BUY
$14.28 - $19.53 $67,116 - $91,791
4,700 Added 19.83%
28,400 $438,000
Q3 2021

Oct 19, 2021
BUY
$12.99 - $20.47 $307,863 - $485,139
23,700 New
23,700 $386,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email